Hoth Therapeutics, Inc. Annual Return On Equity in % from 2018 to 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Hoth Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2024.
  • Hoth Therapeutics, Inc. Return On Equity for the quarter ending December 31, 2024 was -98.8 %, a 35.7% decline year-over-year.
  • Hoth Therapeutics, Inc. annual Return On Equity for 2024 was -98.8 %, a 35.7% decline from 2023.
  • Hoth Therapeutics, Inc. annual Return On Equity for 2023 was -72.8 %, a 45.8% increase from 2022.
  • Hoth Therapeutics, Inc. annual Return On Equity for 2022 was -134 %, a 40.4% decline from 2021.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -98.8 -26 -35.7% Jan 1, 2024 Dec 31, 2024
2023 -72.8 +61.7 +45.8% Jan 1, 2023 Dec 31, 2023
2022 -134 -38.7 -40.4% Jan 1, 2022 Dec 31, 2022
2021 -95.8 +37 +27.8% Jan 1, 2021 Dec 31, 2021
2020 -133 +56.7 +29.9% Jan 1, 2020 Dec 31, 2020
2019 -190 +44.9 +19.1% Jan 1, 2019 Dec 31, 2019
2018 -234 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.